|
Randomized phase 3 trial of ibrutinib/rituximab vs placebo/rituximab in Waldenström's macroglobulinemia. |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genesis Pharmaceuticals; Janssen-Cilag; Novartis; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda |
Research Funding - Amgen (Inst); Janssen-Cilag (Inst) |
Travel, Accommodations, Expenses - Amgen; Genesis Pharmaceuticals; Janssen-Ortho |
|
|
Honoraria - Abbvie; Gilead Sciences; Janssen; Roche |
Consulting or Advisory Role - Abbvie; Janssen |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; Janssen; Takeda |
Research Funding - Hospira; Pharmacyclics; Takeda |
Travel, Accommodations, Expenses - Janssen |
|
|
Honoraria - Gilead Sciences; Janssen; Lundbeck; Roche; Seagen |
|
|
Honoraria - Abbvie; Amgen; Gilead Sciences; Janssen; Roche; Sandoz |
Consulting or Advisory Role - Abbvie; Janssen; Roche |
Speakers' Bureau - Abbvie; Gilead Sciences; Janssen; Roche |
Travel, Accommodations, Expenses - Abbvie; Roche |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; Gilead Sciences; Janssen |
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Janssen |
|
|
|
Consulting or Advisory Role - Janssen |
Research Funding - Janssen |
|
|
Honoraria - Juno Therapeutics; Seres Therapeutics |
Consulting or Advisory Role - Merck; Pharmacyclics; Therakos |
Patents, Royalties, Other Intellectual Property - Juno Therapeutics; Seres Therapeutics |
|
|
Consulting or Advisory Role - Celgene |
Speakers' Bureau - Celgene |
Research Funding - Celgene (Inst); Seagen (Inst) |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Takeda |
Consulting or Advisory Role - Amgen; Genesis Pharmaceuticals; Janssen; Prothena; Takeda |
Travel, Accommodations, Expenses - Janssen; Takeda |
|
|
Consulting or Advisory Role - Janssen; Pharmacyclics |
Research Funding - Janssen; Pharmacyclics |
Other Relationship - Janssen; Pharmacyclics |
|
|
Employment - Pharmacyclics |
Stock and Other Ownership Interests - Abbott; Abbvie; Aduro Biotech; Amgen; Biogen; Bristol-Myers Squibb; Celgene; Exelixis; Gilead Sciences; Isis Pharmaceuticals; Juno Therapeutics; Medivation; Merck; Merrimack; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Gilead Sciences; Janssen; Pfizer; Roche |
Speakers' Bureau - Gilead Sciences; Janssen; Pfizer; Roche |
Research Funding - Janssen; Roche |